wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34365632-5E241F8E-82FD-45F5-BA29-55E96DADD2BF
Q34365632-5E241F8E-82FD-45F5-BA29-55E96DADD2BF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34365632-5E241F8E-82FD-45F5-BA29-55E96DADD2BF
Molecular pathways and targets in prostate cancer
P2860
Q34365632-5E241F8E-82FD-45F5-BA29-55E96DADD2BF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34365632-5E241F8E-82FD-45F5-BA29-55E96DADD2BF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ecda6996f4bdc8c6644367b442edbfcd3f4263c
P2860
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.